CareDx (NASDAQ: CDNA) reported Q2 EPS of $0.10, $0.20 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $86.7 million versus the consensus estimate of $90.62 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.